Proxyfan
 | |
| Names | |
|---|---|
| Preferred IUPAC name 4-[3-(Benzyloxy)propyl]-1H-imidazole | |
| Identifiers | |
CAS Number |
|
3D model (JSmol) |
|
| ChEMBL |
|
| ChemSpider |
|
IUPHAR/BPS |
|
PubChem CID |
|
CompTox Dashboard (EPA) |
|
| |
| Properties | |
Chemical formula | C13H16N2O |
| Molar mass | 216.284 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). Infobox references | |
Chemical compound
Proxyfan is a histamine H3 receptor ligand which is a "protean agonist", producing different effects ranging from full agonist, to antagonist, to inverse agonist in different tissues, depending on the level of constitutive activity of the histamine H3 receptor. This gives it a complex activity profile in vivo which has proven useful for scientific research.[1][2][3][4][5][6][7]
References
- ^ Morisset, S.; Rouleau, A.; Ligneau, X.; Gbahou, F.; Tardivel-Lacombe, J.; Stark, H.; Schunack, W.; Ganellin, C. R.; Schwartz, J. C.; Arrang, J. M. (2000). "High constitutive activity of native H3 receptors regulates histamine neurons in brain". Nature. 408 (6814): 860–864. doi:10.1038/35048583. PMID 11130725.
- ^ Fox, G. B.; Pan, J. B.; Esbenshade, T. A.; Bitner, R. S.; Nikkel, A. L.; Miller, T.; Kang, C. H.; Bennani, Y. L.; Black, L. A.; Faghih, R.; Hancock, A. A.; Decker, M. W. (2002). "Differential in vivo effects of H3 receptor ligands in a new mouse dipsogenia model". Pharmacology, Biochemistry, and Behavior. 72 (3): 741–750. doi:10.1016/s0091-3057(02)00745-1. PMID 12175472.
- ^ Gbahou, F.; Rouleau, A.; Morisset, S.; Parmentier, R.; Crochet, S.; Lin, J. S.; Ligneau, X.; Tardivel-Lacombe, J.; Stark, H.; Schunack, W.; Ganellin, C. R.; Schwartz, J. C.; Arrang, J. M. (2003). "Protean agonism at histamine H3 receptors in vitro and in vivo". Proceedings of the National Academy of Sciences of the United States of America. 100 (19): 11086–11091. doi:10.1073/pnas.1932276100. PMC 196931. PMID 12960366.
- ^ Baldi, E.; Bucherelli, C.; Schunack, W.; Cenni, G.; Blandina, P.; Passani, M. B. (2005). "The H3 receptor protean agonist proxyfan enhances the expression of fear memory in the rat". Neuropharmacology. 48 (2): 246–251. doi:10.1016/j.neuropharm.2004.09.009. hdl:2158/220558. PMID 15695163.
- ^ Krueger, Kathleen M.; Witte, David G.; Ireland-Denny, Lynne; Miller, Thomas R.; Baranowski, John L.; Buckner, Steve; Milicic, Ivan; Esbenshade, Timothy A.; Hancock, Arthur A. (2005). "G Protein-Dependent Pharmacology of Histamine H3 Receptor Ligands: Evidence for Heterogeneous Active State Receptor Conformations". Journal of Pharmacology and Experimental Therapeutics. 314 (1): 271–281. doi:10.1124/jpet.104.078865. PMID 15821027.
- ^ Arrang, J. M.; Morisset, S.; Gbahou, F. (2007). "Constitutive activity of the histamine H3 receptor". Trends in Pharmacological Sciences. 28 (7): 350–357. doi:10.1016/j.tips.2007.05.002. PMID 17573125.
- ^ Baker, Jillian G. (2008). "Antagonist affinity measurements at the Gi-coupled human histamine H3 receptor expressed in CHO cells". BMC Pharmacology. 8: 9. doi:10.1186/1471-2210-8-9. PMC 2430196. PMID 18538007.
- v
- t
- e
Histamine receptor modulators
| Agonists | |
|---|---|
| Antagonists |
|
| Agonists |
|
|---|---|
| Antagonists |
|
| Agonists |
|
|---|---|
| Antagonists |
|
- See also
- Receptor/signaling modulators
- Monoamine metabolism modulators
- Monoamine reuptake inhibitors
 | This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e
